Literature DB >> 24824874

Interactions of hydrogen sulfide with myeloperoxidase.

Zoltán Pálinkás1, Paul G Furtmüller, Attila Nagy, Christa Jakopitsch, Katharina F Pirker, Marcin Magierowski, Katarzyna Jasnos, John L Wallace, Christian Obinger, Péter Nagy.   

Abstract

BACKGROUND AND
PURPOSE: The actions of hydrogen sulfide in human physiology have been extensively studied and, although it is an essential mediator of many biological functions, the underlying molecular mechanisms of its actions are ill-defined. To elucidate the roles of sulfide in inflammation, we have investigated its interactions with human myeloperoxidase (MPO), a major contributor to inflammatory oxidative stress. EXPERIMENTAL APPROACH: The interactions of sulfide and MPO were investigated using electron paramagnetic resonance, electronic circular dichroism, UV-vis and stopped-flow spectroscopies. KEY
RESULTS: We found favourable reactions between sulfide and the native-ferric enzyme as well as the MPO redox intermediates, ferrous MPO, compound I and compound II. Sulfide was a potent reversible inhibitor of MPO enzymic activity with an IC50 of 1 µM. In addition, the measured second-order rate constants for the reactions of sulfide with compound I [k = (1.1 ± 0.06) × 10(6)  M(-1)  s(-1)] and compound II [k = (2.0 ± 0.03) × 10(5)  M(-1)  s(-1)] suggest that sulfide is a potential substrate for MPO in vivo. CONCLUSION AND IMPLICATIONS: Endogenous levels of sulfide are likely to inhibit the activity of circulating and endothelium-bound MPO. The fully reversible inhibition suggests a mediatory role of sulfide on the oxidant-producing function of the enzyme. Furthermore, the efficient HOCl oxidation of sulfide to give polysulfides (recently recognized as important components of sulfide biology) together with MPO-catalysed sulfide oxidation and the lack of interaction between MPO and sulfide oxidation products, predict a modulatory role of MPO in sulfide signalling.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24824874      PMCID: PMC4369261          DOI: 10.1111/bph.12769

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  74 in total

1.  2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.

Authors:  Anna-Karin Tidén; Tove Sjögren; Mats Svensson; Alexandra Bernlind; Revathy Senthilmohan; Francoise Auchère; Henrietta Norman; Per-Olof Markgren; Susanne Gustavsson; Staffan Schmidt; Stefan Lundquist; Louisa V Forbes; Nicholas J Magon; Louise N Paton; Guy N L Jameson; Håkan Eriksson; Anthony J Kettle
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  Determination of hydrogen sulfide with 5,5'-dithiobis-(2-nitrobenzoic acid), N-ethylmaleimide, and parachloromercuribenzoate.

Authors:  A S Nashef; D T Osuga; R E Feeney
Journal:  Anal Biochem       Date:  1977-05-01       Impact factor: 3.365

3.  Thiocyanate-dependent induction of endothelial cell adhesion molecule expression by phagocyte peroxidases: a novel HOSCN-specific oxidant mechanism to amplify inflammation.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Julia Nguyen; Arne Slungaard
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

Review 4.  Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis.

Authors:  J W Heinecke
Journal:  Curr Opin Lipidol       Date:  1997-10       Impact factor: 4.776

5.  Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation.

Authors:  Matthew Whiteman; Richard Haigh; Joanna M Tarr; Kim M Gooding; Angela C Shore; Paul G Winyard
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

6.  Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl.

Authors:  Hilde Laggner; Markus K Muellner; Sabine Schreier; Brigitte Sturm; Marcela Hermann; Markus Exner; Bernhard M K Gmeiner; Stylianos Kapiotis
Journal:  Free Radic Res       Date:  2007-07

Review 7.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

8.  Kinetics of oxygen binding to ferrous myeloperoxidase.

Authors:  Walter Jantschko; Paul Georg Furtmüller; Martina Zederbauer; Christa Jakopitsch; Christian Obinger
Journal:  Arch Biochem Biophys       Date:  2004-06-01       Impact factor: 4.013

9.  Hydrogen sulfide protects neurons from oxidative stress.

Authors:  Yuka Kimura; Hideo Kimura
Journal:  FASEB J       Date:  2004-05-20       Impact factor: 5.191

10.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more
  31 in total

1.  A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

Authors:  Xu Cao; Lei Ding; Zhi-Zhong Xie; Yong Yang; Matthew Whiteman; Philip K Moore; Jin-Song Bian
Journal:  Antioxid Redox Signal       Date:  2018-06-29       Impact factor: 8.401

2.  Pharmacology of the 'gasotransmitters' NO, CO and H2S: translational opportunities.

Authors:  Andreas Papapetropoulos; Roberta Foresti; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2015-03       Impact factor: 8.739

Review 3.  Functional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration.

Authors:  Nilkantha Sen
Journal:  J Mol Biol       Date:  2016-12-21       Impact factor: 5.469

Review 4.  Redox chemistry and chemical biology of H2S, hydropersulfides, and derived species: implications of their possible biological activity and utility.

Authors:  Katsuhiko Ono; Takaaki Akaike; Tomohiro Sawa; Yoshito Kumagai; David A Wink; Dean J Tantillo; Adrian J Hobbs; Peter Nagy; Ming Xian; Joseph Lin; Jon M Fukuto
Journal:  Free Radic Biol Med       Date:  2014-09-16       Impact factor: 7.376

5.  Sulfide Protects Staphylococcus aureus from Aminoglycoside Antibiotics but Cannot Be Regarded as a General Defense Mechanism against Antibiotics.

Authors:  Julia Weikum; Niklas Ritzmann; Nils Jelden; Anna Klöckner; Sebastian Herkersdorf; Michaele Josten; Hans-Georg Sahl; Fabian Grein
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  H2S, a Bacterial Defense Mechanism against the Host Immune Response.

Authors:  Tracy Toliver-Kinsky; Weihua Cui; Gabor Törö; Seung-Jin Lee; Konstantin Shatalin; Evgeny Nudler; Csaba Szabo
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

Review 7.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

8.  Speciation of reactive sulfur species and their reactions with alkylating agents: do we have any clue about what is present inside the cell?

Authors:  Virág Bogdándi; Tomoaki Ida; Thomas R Sutton; Christopher Bianco; Tamás Ditrói; Grielof Koster; Hillary A Henthorn; Magda Minnion; John P Toscano; Albert van der Vliet; Michael D Pluth; Martin Feelisch; Jon M Fukuto; Takaaki Akaike; Péter Nagy
Journal:  Br J Pharmacol       Date:  2018-08-23       Impact factor: 8.739

Review 9.  Chemical Biology of H2S Signaling through Persulfidation.

Authors:  Milos R Filipovic; Jasmina Zivanovic; Beatriz Alvarez; Ruma Banerjee
Journal:  Chem Rev       Date:  2017-11-07       Impact factor: 60.622

10.  Toward More GI-Friendly Anti-Inflammatory Medications.

Authors:  John L Wallace; Gilberto de Nucci; Oksana Sulaieva
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.